Patent details
EP3897844
Title:
PHARMACEUTICAL COMBINATION OF ANTI CEACAM6 AND TIM3 ANTIBODIES
Basic Information
- Publication number:
- EP3897844
- PCT Application Number:
- EP2019084849
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP198167553
- PCT Publication Number:
- WO2020126808
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMBINATION OF ANTI CEACAM6 AND TIM3 ANTIBODIES
- French Title of Invention:
- COMBINAISON PHARMACEUTIQUE DES ANTICOPRS ANTI-CEACAM6 ET ANTI-TIM3
- German Title of Invention:
- PHARMAZEUTISCHE KOMBINATION VON ANTI-CEACAM6- UND TIM3-ANTIKÖRPERN
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 12/12/2023
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 18/12/2023
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 15/11/2023
- Unitary Effect Registration Date:
- 18/12/2023
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 12/12/2019
- Grant date:
- 15/11/2023
- EP Publication Date:
- 27/10/2021
- PCT Publication Date:
- 25/06/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/11/2023
- EP B1 Publication Date:
- 15/11/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 12/12/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/11/2023
-
-
- Name:
- Deutsches Krebsforschungszentrum
- Address:
- Im Neuenheimer Feld 280, 69120 Heidelberg, Germany (DE)
Inventor
1
- Name:
- OFFRINGA, Rienk
- Address:
- Germany (DE)
2
- Name:
- TRAUTWEIN, Mark
- Address:
- Germany (DE)
3
- Name:
- WILLUDA, Jörg
- Address:
- Germany (DE)
4
- Name:
- BÖHM, Hans-Henning
- Address:
- Germany (DE)
5
- Name:
- BECKHOVE, Philipp
- Address:
- Germany (DE)
Priority
- Priority Number:
- 18214059
- Priority Date:
- 19/12/2018
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
-
A61P 35/00;
C07K 16/28;
Publication
European Patent Bulletin
1
- Issue number:
- 202346
- Publication date:
- 15/11/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202403
- Publication date:
- 17/01/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202403
- Publication date:
- 17/01/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
| Filing date |
Document type |
Number of pages |